Items where Author is "Leijer, J.H. de"
![]() | Up a level |
Number of items: 1.
Leijer, J.H. de (2021) REDO trial: Rituximab dose-dependent infection risk in rheumatoid arthritis not mediated through immunoglobulins, neutrophils or B-cells. thesis, Medicine.
![]() | Up a level |
Leijer, J.H. de (2021) REDO trial: Rituximab dose-dependent infection risk in rheumatoid arthritis not mediated through immunoglobulins, neutrophils or B-cells. thesis, Medicine.